lenalidomide has been researched along with moxifloxacin in 2 studies
Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) |
---|---|---|---|---|---|
3,532 | 725 | 2,850 | 3,157 | 552 | 1,690 |
Protein | Taxonomy | lenalidomide (IC50) | moxifloxacin (IC50) |
---|---|---|---|
DNA gyrase subunit B | Staphylococcus aureus | 5.1033 | |
DNA gyrase subunit A | Escherichia coli K-12 | 1.4 | |
DNA gyrase subunit B | Escherichia coli K-12 | 1.4 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.8 | |
DNA gyrase subunit A | Staphylococcus aureus | 7.25 | |
DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 8.525 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 8.66 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Assaf, MS; Chen, N; Kasserra, C; Liu, L; Palmisano, M; Reyes, J; Ye, Y; Zhou, S | 1 |
1 review(s) available for lenalidomide and moxifloxacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lenalidomide and moxifloxacin
Article | Year |
---|---|
Lenalidomide at therapeutic and supratherapeutic doses does not prolong QTc intervals in the thorough QTc study conducted in healthy men.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Electrocardiography; Fluoroquinolones; Humans; Lenalidomide; Male; Middle Aged; Moxifloxacin; Quinolines; Thalidomide; Young Adult | 2013 |